India's drug authority intensifies oversight on generic GLP-1 drugs to prevent misuse and ensure safe distribution and use.
With generic versions of semaglutide being launched over the weekend at lower prices, the Indian drug regulatory authority has upped surveillance on the supply chain and unauthorised sale and promoti… [+2302 chars]
